Jonathan Behr, Ph.D.
Partner at DDF and biotech venture investor
United States
Summary
Experienced life‑science investor and venture creator with a track record of founding and supporting companies and building mission‑driven funds. svhealthinvestors+1
Specializes in neurodegeneration and dementia investments, co‑leading the Dementia Discovery Fund and directing capital toward companies addressing Alzheimer’s, Parkinson’s, ALS and related disorders. svhealthinvestors+2
Active board and observer participant across a broad portfolio of early‑stage biotech companies, working through board governance and investor oversight to advance programs toward clinical development and strategic exits. svhealthinvestors+3
Brings deep academic and translational credentials — an MIT Ph.D. in Biological Engineering and a Rice University B.S. in Bioengineering — which inform his focus on translating neuroscience research into therapeutic companies. svhealthinvestors+1
Work
Education
Writing
Mission-Driven Dementia Funding with DDF's Jonathan Behr
June 1, 2024Podcast/interview discussing Jonathan Behr's transition from academic training to biotech investing and the Dementia Discovery Fund's mission-driven investment approach.
How MIT's PhD Program Prepared DDF's Jonathan Behr For Biotech Investing
June 1, 2024Article/interview covering Behr's academic background at MIT and how his training influenced his career in biotech venture investing.
SV Health Investors announcement: appointment of Jonathan Behr as Partner in the Dementia Discovery Fund
January 1, 2019Press announcement describing Behr's appointment to DDF leadership and summarizing his prior roles in venture creation and fund leadership.